FASENRA approved for treatment of children aged 6 to 11 with severe asthma
Additional indication for pediatric patients with severe eosinophilic asthma ...
Stay updated with breaking news from Safety Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Additional indication for pediatric patients with severe eosinophilic asthma ...
Workplace Options (WPO) Debuts Data-Driven Study Across 9 Nations; Explores Workplace Issues, Need for Inclusive Leadership, and Renewed Commitment...
The approval expands the prior indication of idecabtagene vicleucel (Abecma; Bristol Myers Squibb), which will make the drug available to patients in earlier lines.
Workplace Options presents first global study on how psychological safety affects employees in nine nations utilizing data from WPO clinicians-no surveys....
Vadadustat (Vafseo; Akebia Therapeutics Inc) is indicated for individuals with chronic kidney disease who have been receiving dialysis for at least 3 months.